AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $554.0M, listed on NASDAQ, employing roughly 57 people, carrying a beta of 0.00 to the broader market. AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. Led by Tim Knotnerus, public since 2024-05-29.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for AGMB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.